Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MHC class I peptide-binding groove presenting the SIINFEKL peptide is a cornerstone model in immunology, representing the H-2Kb molecule (UniProt: P01899) complexed with the immunodominant octapeptide from chicken ovalbumin (OVA). This complex is essential for studying the mechanisms of antigen processing and presentation to CD8+ T cells, particularly using the OT-I transgenic mouse model (PubMed: 7504010). Biologically, the complex is formed within the endoplasmic reticulum and transported to the cell surface, where it acts as a specific ligand for the T-cell receptor (TCR). In research and drug development, it is used as a target for TCR-like antibodies, such as the 25-D1.16 clone (PubMed: 8246777), and to evaluate the potency of vaccines and T-cell-based therapies. While the SIINFEKL peptide itself is not a human pathogen-derived antigen, the system serves as a high-affinity proxy for understanding how the immune system identifies and eliminates cells presenting non-self or mutated self-peptides. Consequently, it is a vital tool in the development of immunotherapies for cancer and infectious diseases.
The complex acts as a ligand for the T-cell receptor (TCR) on CD8+ cytotoxic T lymphocytes, triggering signal transduction and immune effector functions.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H-2 class I histocompatibility antigen, K-B alpha chain presenting SIINFEKL peptide (H-2Kb-SIINFEKL).